These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29112700)

  • 1. Reply: Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?
    Schüle R
    Brain; 2017 Dec; 140(12):e74. PubMed ID: 29112700
    [No Abstract]   [Full Text] [Related]  

  • 2. Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?
    de Bot S; Kamsteeg EJ; Van De Warrenburg BPC
    Brain; 2017 Dec; 140(12):e73. PubMed ID: 29112699
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel homozygous mutation in ATP13A2 gene causing pure hereditary spastic paraplegia.
    Ban R; Pu C; Fang F; Shi Q
    Parkinsonism Relat Disord; 2021 May; 86():58-60. PubMed ID: 33862550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia.
    Miranda M; Harmuth F; Bustamante ML; Rossi M; Sturm M; Magnusson ÓT; Bauer P; Klockgether T; Ramirez A
    Parkinsonism Relat Disord; 2020 Dec; 81():45-47. PubMed ID: 33049588
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel mutation in ATP13A2 gene in a patient with complicated hereditary spastic paraplegia accompanied by tubulopathy.
    Inan B; Azman F; Aktas D; Yildiz Y; Saygi S
    Acta Neurol Belg; 2023 Oct; 123(5):1985-1987. PubMed ID: 35789476
    [No Abstract]   [Full Text] [Related]  

  • 7. From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.
    Erro R; Picillo M; Manara R; Pellecchia MT; Barone P
    Parkinsonism Relat Disord; 2019 Aug; 65():272-273. PubMed ID: 31151786
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype.
    Estiar MA; Leveille E; Spiegelman D; Dupre N; Trempe JF; Rouleau GA; Gan-Or Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1052. PubMed ID: 31944623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to: "Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion".
    De la Casa-Fages B; Fernández-Eulate G; Gamez J; Barahona-Hernando R; Morís G; García-Barcina M; Infante J; Zulaica M; Fernández-Pelayo U; Muñoz-Oreja M; Urtasun M; Olaskoaga A; Zelaya V; Jericó I; Saez-Villaverde R; Catalina I; Sola E; Martínez-Sáez E; Pujol A; Ruiz M; Schlüter A; Spinazzola A; Muñoz-Blanco JL; Grandas F; Holt I; Álvarez V; López de Munaín A
    Mov Disord; 2019 Dec; 34(12):1932-1933. PubMed ID: 31845766
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and phenotypic characterization of complex hereditary spastic paraplegia.
    Kara E; Tucci A; Manzoni C; Lynch DS; Elpidorou M; Bettencourt C; Chelban V; Manole A; Hamed SA; Haridy NA; Federoff M; Preza E; Hughes D; Pittman A; Jaunmuktane Z; Brandner S; Xiromerisiou G; Wiethoff S; Schottlaender L; Proukakis C; Morris H; Warner T; Bhatia KP; Korlipara LV; Singleton AB; Hardy J; Wood NW; Lewis PA; Houlden H
    Brain; 2016 Jul; 139(Pt 7):1904-18. PubMed ID: 27217339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia.
    Koh K; Ichinose Y; Ishiura H; Nan H; Mitsui J; Takahashi J; Sato W; Itoh Y; Hoshino K; Tsuji S; Takiyama Y;
    J Hum Genet; 2019 Jan; 64(1):55-59. PubMed ID: 30302010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
    Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
    Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
    Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism.
    De la Casa-Fages B; Fernández-Eulate G; Gamez J; Barahona-Hernando R; Morís G; García-Barcina M; Infante J; Zulaica M; Fernández-Pelayo U; Muñoz-Oreja M; Urtasun M; Olaskoaga A; Zelaya V; Jericó I; Saez-Villaverde R; Catalina I; Sola E; Martínez-Sáez E; Pujol A; Ruiz M; Schlüter A; Spinazzola A; Muñoz-Blanco JL; Grandas F; Holt I; Álvarez V; López de Munaín A
    Mov Disord; 2019 Oct; 34(10):1547-1561. PubMed ID: 31433872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset parkinsonism and hereditary spastic paraplegia type 7: pearls and pitfalls.
    Phillips O; Amato AM; Fernandez HH
    Parkinsonism Relat Disord; 2023 May; 110():105315. PubMed ID: 36754704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia.
    Paisan-Ruiz C; Dogu O; Yilmaz A; Houlden H; Singleton A
    Neurology; 2008 Apr; 70(16 Pt 2):1384-9. PubMed ID: 18337587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion.
    Finsterer J
    Mov Disord; 2019 Dec; 34(12):1931-1932. PubMed ID: 31845759
    [No Abstract]   [Full Text] [Related]  

  • 19. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP13A2-related juvenile-onset Parkinson disease.
    Suleiman J; El-Hattab AW
    Brain Dev; 2019 Feb; 41(2):223. PubMed ID: 30144971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.